Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2644 of 5804
-
Diabetes drug may help fatty liver – new study investigates
Knowledge-focused CompletedMetabolic dysfunction-associated steatotic liver disease (MASLD), a condition where fat builds up in the liver, is common in patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT2) inhibitors may help improve liver health, but their effects on liver stiffness and fa…
Sponsor: Josip Juraj Strossmayer University of Osijek • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New app aims to help hispanic kids breathe easier
Disease control CompletedThis is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.
Phase: NA • Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Gentle touch or core strength? trial tests best combo for back pain
Symptom relief CompletedThis randomized controlled trial aims to compare the effectiveness of Bowen Therapy combined with McGill stabilization exercises versus Bowen Therapy alone in individuals with chronic nonspecific low back pain. The study will evaluate changes in pain intensity, lumbar range of mo…
Phase: NA • Sponsor: Sehat Medical Complex • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
When to start walking rehab after spinal injury? new study seeks answer.
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate if a specific type of additional walking therapy, called body weight supported treadmill training (BWSTT) affects walking ability following a traumatic spinal cord injury. Specifically, the study will look at whether starting BWSTT, which …
Phase: NA • Sponsor: Milap Sandhu • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Coffee break for cancer survivors: could your morning cup fight liver fat?
Disease control Recruiting nowThis is research study is assessing the effects of 6-g daily use of freeze-dried instant coffee on liver fat and fibrosis and the gut microbiome and metabolome in patients who have completed routine treatment (including surgery, chemotherapy and radiotherapy) for stage I-III colo…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Lung cancer combo trial halted early: what happened?
Disease control TerminatedThe purpose of this study was to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered to participants with non-small cell lung cancer (NSCLC) following resection and adjuvant chemotherapy.
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New program boosts HIV prevention in young men
Prevention CompletedThe proposed study will involve adolescent (17-24 years old) men who have sex with men (described as YMSM hereafter) who meet eligibility criteria to participate. Prospective study candidates will receive a copy of the IRB-approved informed consent forms and, if they choose to pa…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Vitamin B6 shows promise for diabetes blood vessel health
Disease control CompletedPatients with type 2 diabetes have an increased risk of developing vascular complications. Microvascular dysfunction might be caused by the increased production of methylglyoxal under hyperglycaemic conditions. Methylglyoxal is a by-product of glycolysis and forms advanced glycat…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New Gene-Targeting drug could change how we treat high blood pressure
Disease control OngoingThis Phase 1 study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ADX-850 in participants with hypertension.
Phase: PHASE1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Acupuncture needles vs. sepsis: a bold new trial
Symptom relief Recruiting nowResearchers think acupuncture may improve outcomes for participants with sepsis, based on laboratory studies and previous studies in people with sepsis. The purpose of this study to see whether real acupuncture can improve outcomes for participants with sepsis when compared to sh…
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Tooth infection treatment showdown: MTA vs. standard sealers
Disease control CompletedThis project is a randomized controlled clinical study investigating the effect of Mineral Trioxide Aggregate (MTA) used as an apical plug in root canal obturation on periodontal healing and inflammatory biomarkers in teeth with combined endodontic-periodontal (endo-perio) lesion…
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could an 'Exercise-in-a-Pill' replace workouts for heart failure?
Knowledge-focused Recruiting nowThe heart failure syndrome that occurs when the heart is too sick to properly do its job. One of the main symptoms is difficulty with exercise. One way to improve symptoms is to start patients in a 12 week exercise program called cardiac rehabilitation. Cardiac rehabilitation bee…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New depression pill shows promise in quick mood lift
Symptom relief CompletedTo evaluate the efficacy, safety, and tolerability of NBI-1070770 compared to placebo on improving symptoms of depression in participants with major depressive disorder (MDD).
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Art as medicine: study shows creative activities may ease anxiety and depression
Symptom relief CompletedStratified randomised controlled trial with two arms: arts intervention (any of the arts interventions, see list), which we call here Active Group (AG) vs waitlist control (WL).
Phase: NA • Sponsor: KAVADIA ELENI • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can your sleep length predict the best insomnia cure?
Symptom relief Recruiting nowIndividuals who have insomnia with short sleep duration (ISS) differ from individuals who have insomnia with normal sleep duration (INS) in terms of health risks (i.e., hypertension) and treatment response. This study will examine whether patients with ISS and INS demonstrate a d…
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a simple nerve zap treat erectile dysfunction?
Symptom relief OngoingErectile dysfunction is known as any alteration that produces a modification in the erectile response, whether of organic, psychogenic or relational cause. In this case the pudendal nerve is addressed, since it has its origin in the sacral plexus, deriving from the S2, S3 and S4 …
Phase: NA • Sponsor: Camilo Jose Cela University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail targets Hard-to-Treat ovarian and uterine cancers
Disease control OngoingThis is a phase 1 study to evaluate investigational drug RP-6306 in combination with carboplatin and paclitaxel in patients with TP53 mutated ovarian or uterine cancer. The dose escalation part of the study will determine the maximum tolerated dose (MTD) and recommended Phase 2 D…
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Experimental drug aims to keep viral pneumonia patients out of hospital
Disease control TerminatedThis is a Phase II, multi-center, double-blind, randomized, interventional study in approximately 120 subjects to evaluate clinical benefit of CX-4945 in adult outpatients with SARS-CoV-2 and influenza viral infection-associated pneumonia. The subjects will be recruited into two …
Phase: PHASE2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a smartphone app replace the gym for teens with arthritis?
Symptom relief CompletedJuvenile Idiopathic Arthritis (JIA) is a heterogeneous, idiopathic, chronic inflammatory, rheumatic disease that is most common in childhood and is thought to involve immunological mechanisms in its etiopathogenesis. Exercise and physical activity (PA) approaches have an importan…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 26, 2026 17:16 UTC
-
Could a common allergy drug boost brain power in kids with williams syndrome?
Disease control CompletedThis study focuses on therapeutic targets for cognitive, motor, and social impairments in Williams syndrome by reversing brain myelin defects caused by GTF2I. The primary objective of the study was to test and evaluate the initial efficacy and safety of Clomastine fumarate in the…
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC